[CUTANEOUS AND MUCOUS LIPOPROTEINOSIS OR CUTANEOUS AND MUCOUS HYALINOSIS (URBACH-WIETHE DISEASE)].
D000279:Administration, Cutaneous; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D002648:Child; D003241:Consanguinity; D005190:Family; D005826:Genetics, Medical; D006801:Humans; D050356:Lipid Metabolism; D008052:Lipid Metabolism, Inborn Errors; D008065:Lipoid Proteinosis of Urbach and Wiethe; D009092:Mucous Membrane; D009093:Mucus; D010118:Oxytetracycline; D011241:Prednisone / Q000627:therapeutic use*; D014827:Vocal Cords
D000324:Adrenocorticotropic Hormone; D011241:Prednisone; D010118:Oxytetracycline
CHILD; CONSANGUINITY; CORTICOTROPIN, THERAPEUTIC; GENETICS, HUMAN; LIPID METABOLISM, INBORN ERRORS; MUCOUS MEMBRANE; OXYTETRACYCLINE; PREDNISONE, THERAPEUTIC; VOCAL CORDS
LIPOPROTEINOSIS CUTIS ET MUCOSAE SIVE HYALINOSIS CUTIS ET MUCOSAE (MORBUS URBACH-WIETHE)